0001209191-16-140999.txt : 20160912 0001209191-16-140999.hdr.sgml : 20160912 20160912202342 ACCESSION NUMBER: 0001209191-16-140999 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160908 FILED AS OF DATE: 20160912 DATE AS OF CHANGE: 20160912 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC CENTRAL INDEX KEY: 0001175505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260038620 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-365-5600 MAIL ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Borges Luis CENTRAL INDEX KEY: 0001684015 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36070 FILM NUMBER: 161881871 MAIL ADDRESS: STREET 1: TWO CORPORATE DRIVE STREET 2: C/O FIVE PRIME THERAPEUTICS, INC. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2016-09-08 0 0001175505 FIVE PRIME THERAPEUTICS INC FPRX 0001684015 Borges Luis TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 0 1 0 0 SVP, Research Common Stock 66622 D Employee Stock Option (right to buy) 13.47 2024-05-13 Common Stock 16000 D Employee Stock Option (right to buy) 19.25 2025-08-17 Common Stock 20000 D Employee Stock Option (right to buy) 43.71 2026-08-25 Common Stock 17000 D One fourth (1/4th) of the shares underlying the option vested on May 12, 2015, and the remainder of the shares underlying the option vest at a rate of one forty-eighth (1/48th) per month thereafter, provided the reporting person remains employed by Five Prime Therapeutics, Inc. (the "Company") through each such date. One forty-eighth (1/48th) of the shares underlying the option vest monthly beginning September 17, 2015, provided the reporting person remains employed by the Company through each such date. One forty-eighth (1/48th) of the shares underlying the option vest monthly beginning September 25, 2016, provided the reporting person remains employed by the Company through each such date. /s/ Francis Sarena, Attorney-in-fact 2016-09-12